Cardiometabolic Therapeutics
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Dia Beta Labs wins AIMS Summit 2026 Shark Tank Competition
Northern Irish biotech company takes top honours after presenting its first-in-class metabolic disease therapeutic to an international panel of investors and innovation leaders. 15th September 2026 Dia Beta Labs Ltd (DBL) has been named the overall winner
Read more
Report
Prof. Peter Flatt Named in King's Honours' List
We are delighted to share news that Professor Peter Flatt, esteemed member of Dia Beta Lab's Scientific committee, has been awarded an MBE in the King's Birthday Honours List, recognising an extraordinary career spanning more than four decades in diabetes
Read more
Report
INVENT Winners 2024!
Dia Beta Labs are delighted to announce that we have been selected as the overall winners of the annual INVENT Competition for startup companies! Organised by the Northern Ireland science and technology hub, Catalyst with headline partner Bank of Ireland
Read more
Report
DBL Secure NI Launchpad Funding from Innovate UK for Gender-Balanced Research
9th May 2024 Dia Beta Labs are delighted to announce the securing of further grant funding from the UK's innovation agency, Innovate UK through the Northern Ireland Life & Health Sciences Launchpad! This £99K award facilitates performance of a confirmator
Read more
Report
DBL Members Co-Author Publication on the Promise of Multiagonist Peptide Therapies for Obesity
Following the recent approval of GLP-1R (glucagon-like peptide-1 receptor) agonist therapies for the pharmacological management of obesity over the last number of months, peptide therapies have become a particularly hot topic. Indeed, unless they had a di
Read more
Report
DBL's Novel Approach to Diabetes Management Highlighted by The Irish Times
Dia Beta Labs' CEO, Dr. Ryan Lafferty, took the opportunity to sit down with Barry McCall, Business Editor for the Irish Times, to discuss the exciting work currently underway at DBL in the development of our disease-modifying antidiabetic therapies. You
Read more
Report
Dia Beta Labs Feature by HIRANI
In light of World Diabetes Day on 14th November, our CEO, Dr. Ryan Lafferty, was delighted to engage with The Health Innovation Research Alliance Northern Ireland (HIRANI) to discuss the importance of innovation in management of the condition. You can rea
Read more
Report
Business Spotlight UK Interview
Our very own CEO, Dr. Ryan Lafferty, sat down with Scott Millar from Business Spotlight UK to discuss all things Dia Beta Labs! Why not take 15 minutes out of your day to learn about our journey from concept to spin-out, Ryan's transition from academia to
Read more
Report
